Bio Rad Laboratories Inc (NYSE:BIO)
| 559.29 Delayed Data As of 3:59pm ET |  -30.25 / -5.13%Today’s Change | 309.38 Today|||52-Week Range 592.66 | +51.15% Year-to-Date |
Latest BIO News | Press Releases
| Medical Products' Oct 29 Earnings Roster: SYK, BAX & More 9:53am / Zacks.com - Paid Partner Content | Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Oct 22 / Zacks.com - Paid Partner Content |
| Bio-Rad (BIO) to Report Q3 Earnings: What's in the Cards? Oct 23 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 589.54 |
| Today’s open | 577.45 |
| Day’s range | 558.51 - 583.97 |
| Volume | 184,962 |
| Average volume (3 months) | 176,187 |
| Market cap | $14.3B |
Data as of 3:59pm ET, 10/28/2020
Growth & Valuation
| Earnings growth (last year) | +380.91% |
| Earnings growth (this year) | +12.23% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +0.97% |
| P/E ratio | 8.7 |
| Price/Sales | 4.83 |
| Price/Book | 3.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PKIPerkinElmer Inc | -2.47 | -1.94% |
| WATWaters Corp | +0.85 | +0.38% |
| QGENQiagen NV | -1.32 | -2.64% |
| BRKRBruker Corp | -1.47 | -3.44% |
Data as of 4:00pm ET, 10/28/2020
Financials
| Next reporting date | October 30, 2020 |
| EPS forecast (this quarter) | $1.80 |
| Annual revenue (last year) | $2.3B |
| Annual profit (last year) | $1.8B |
| Net profit margin | 76.08% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Hercules, California |
Forecasts
